Evidence map›Paper›PMID 22832587›Full record

ArticleWorld journal of urology2012

Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy?

Michael Rink, Shahrokh F Shariat, Evanguelos Xylinas, John P Fitzgerald, Jens Hansen, David A Green, Ashish M Kamat, Giacomo Novara, Siamak Daneshmand, Yves Fradet and 14 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in World journal of urology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 15 institutions in 5 countries.

Michael RinkBrady Urologic Health Center, Weill Cornell Medical College of Cornell University, New York Presbyterian Hospital, 525 East 68th Street, Box 94, Starr 900, New York, NY, USA.
Shahrokh F Shariat
Evanguelos Xylinas
John P Fitzgerald
Jens Hansen
David A Green
Ashish M Kamat
Giacomo Novara
Siamak Daneshmand
Yves Fradet
Scott T Tagawa
Patrick J Bastian
Wassim Kassouf
Quoc-Dien Trinh
Pierre I Karakiewicz
Hans-Martin Fritsche
Derya Tilki
Felix K Chun
Bjoern G Volkmer
Marko Babjuk
Axel S Merseburger
Douglas S Scherr
Yair Lotan
Robert S Svatek
NewYork–Presbyterian Hospital · USMünchen Klinik · DEThe University of Texas Health Science Center at San Antonio · USUniversität Hamburg · DEUniversité de Montréal · CACharles University · CZKlinikum Kassel · DEMcGill University Health Centre · CAMedizinische Hochschule Hannover · DEThe University of Texas MD Anderson Cancer Center · USThe University of Texas Southwestern Medical Center · USUniversité Laval · CAUniversity of Padua · ITUniversity of Regensburg · DEUniversity of Southern California · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo determine whether the number of lymph nodes (LNs) examined is associated with outcomes in patients without nodal metastasis after radical cystectomy (RC). PATIENTS AND

methodsWe retrospectively analyzed data from 4,188 patients treated at 12 centers with RC and pelvic lymphadenectomy without neo-adjuvant chemotherapy for urothelial carcinoma of the bladder (UCB). Outcomes of patients without LN metastasis (n = 3,088) were examined according to the LN yield analyzed as continuous variable, tertiles, and using the cutoffs of ≥ 9 and ≥ 20.

resultsThe median nodal yield was 18 (range 1-123; IQR:20). A total of 2591 (84 %) and 1445 (47 %) patients had a LN yield ≥ 9 and ≥ 20, respectively. Median follow-up was 47 months (IQR:70). In multivariable analyses that adjusted for the standard clinicopathologic factors, higher LN yield was associated with a decreased risk of disease recurrence (continuous: HR = 0.996, p = 0.05; 3rd vs 1st tertile: HR = 0.853, p = 0.048; cutoff ≥ 20: HR = 0.851, p = 0.032). In the subgroups of patients with muscle-invasive UCB or those with ≥ 9 LN removed, LN yield was not associated with outcomes (p values >0.05).

conclusionsIn this large multicenter cohort of patients with node-negative UCB, higher nodal yield improved recurrence-free survival when all patients were analyzed. Patients with a high LN yield (≥ 20 LN removed or 3rd tertile) had the largest benefit. The lack of prognostic significance of LN yield in patients with muscle-invasive UCB or those stratified by 9 LNs removed suggests that this effect is weak. Further prospective studies are needed to help identify preoperatively the optimal template for each patient.

Indexed as

Lymphatic MetastasisLymph Node ExcisionAgedAged, 80 and overCarcinoma, Transitional CellCohort StudiesCystectomyFemaleHumansIncidenceLymph NodesMaleMiddle AgedMultivariate AnalysisNeoplasm Recurrence, LocalPrognosis

Identifiers

PMID22832587
OpenAlexW1998641052

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.